Searched for
TORRENT PHARMACEUTICALS BRAZIL
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...- Hold Torrent Pharma, target price Rs 3,320: JM FinancialJM Financial recommends holding Torrent Pharmaceuticals with a target price of Rs 3,320, up from its current Rs 3,044.3. The company, a maj...
- Torrent Pharma shares fall 3% after 2.9% stake sale via block dealTorrent Pharma Share Price: Torrent Pharmaceuticals reported a consolidated profit after tax (PAT) of Rs 453 crore in the September quarter...
- Torrent Pharma promoter to sell up to 2.9% stake via block deal on Oct 30: ReportTorrent Pharmaceuticals promoter is likely to sell a 2.9% stake worth Rs 3,000 crore via block deal on Wednesday. The offer price is likely...
- Torrent Pharma net profit jumps 21% to Rs 457 crore in Q1FY25India sales that constitute 57% of Torrent's revenues grew 15% YoY to Rs 1,635 crores in Q1FY25 led by outperformance in focus therapies.
- Torrent Pharma Q2 Results: Profit rise on strong demandConsolidated net profit was 3.86 billion rupees ($46.4 million) for the quarter ended Sept. 30, compared with 3.12 billion rupees a year ea...
- Torrent Pharma Q2 Results: Firm posts 1% drop in PAT to Rs 312 croreRevenues rose 7% YoY to Rs 2,291 crore during Q2FY23
- Torrent Pharma Q2 Results: Firm posts 1% drop in net profit to Rs 312 croreRevenues rose 7% YoY to Rs 2,291 crore during Q2FY23, compared to Rs 2,137 crore in Q2FY22.
- Buy Torrent Pharmaceuticals, target price Rs 1769: ICICI SecuritiesTorrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Export Incentives for the y...
- Torrent Pharma Q1 results: Net profit up 2.8% to Rs 330 crConsolidated revenue from operations of the company stood at Rs 2,134 crore for the quarter under consideration. It was Rs 2,056 crore for ...
- Neutral on Torrent Pharma, target price Rs 2520: Motilal OswalTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 43659.46 Crore) operating in...
- Torrent Pharma Q4 results: Posts net profit of Rs 314 croreThe company had posted a net loss of Rs 152 crore for the corresponding period of the previous financial year.
- Buy Torrent Pharmaceuticals, target Rs 1570 : Edelweiss Financial ServicesBuy Torrent Pharmaceuticals Ltd. at a price target of Rs 1570 and that target can be reached in a year.
- Buy Torrent Pharmaceuticals with a target of Rs 1665: Edelweiss Financial ServicesTorrent Pharma is significantly ramping up in US with ~100 filings targeted over next 3 years
- Buy Torrent Pharmaceuticals Ltd., target Rs 1672.0 : Deutsche Bank ResearchA strong growth in Brazil has offset sluggish growth recorded in India, the global investment bank said
- Torrent Pharma commences production from new plant in GujaratTorrent Pharma said it has commenced production from its new plant in Gujarat, the first phase of which has come up at an investment of ove...
- Torrent Pharma plunges over 8% as Q3 results disappointThe company reported a net profit of Rs 167 crore, up 6 per cent, from a net profit of Rs 158 crore, in the corresponding quarter last fisc...
- Torrent Pharma Q2 7% de-growth in Brazil, net profit up by 7%Torrent Pharmaceuticals Ltd, Q2 registered 7% revenue de-growth in Brazil, consolidated Q2 net profit grew by 7% and revenue by 13%.
- Torrent Pharma Q3 consolidated net up 8.15% to Rs 83.18 crThe company had posted a consolidated net profit of Rs 76.91 crore for the quarter ended December 31, 2010, Torrent Pharmaceuticals said in...
- Torrent Pharma Q3 net down 7.28 pc to Rs 76.91 crThe company's Brazil sales increased to Rs 102 crore for the third quarter, compared to Rs 89 crore in the same period last fiscal.
Load More
